Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.


TSXV:ARCH - Post by User

Comment by Viking2233on Jul 16, 2023 9:56am
89 Views
Post# 35543125

RE:RE:Shorts

RE:RE:Shorts

Tech Titan, there is a simple reason you have zero likes  since your inception, you have nothing of value to add. Why are you even viewing this board? Why would you comment on this board.

It is healthy to have both bull and bear comments listed but simply posting to attack a person has no value to anyone.

If you have valid comments regarding the company, its science or trials that support your negative view, then please post your comments along with supporting facts to demonstrate your opinion.

I believe this is not the first time you have popped up here attacking a poster.



TechTitan wrote: "Fingers crossed CIBC and Scotia shorts are gone"...Why post your tears here for them to read? 

$10 a share!? Then $50+ a share!??? Haha Wow! Get real and look at that chart. This can barely hang on above $1.50 US / 2$ CAD right now. 

 

<< Previous
Bullboard Posts
Next >>